cinclus pharma header shaking hands

Licenced partners

Licenced partners



Jiangsu Sinorda Biomedicine Co. Ltd

Cinclus Pharma has a license agreement with Jiangsu Sinorda Biomedicine Co., Ltd (“Sinorda”) for the development and commercialization of linaprazan glurate in China and other selected regions of Asia. Sinorda has in turn exclusively sub-licensed the manufacturing and industrial sales rights for linaprazan glurate in China, Hong Kong, Macau and Taiwan to SPH Sine Pharmaceutical Laboratories Co., Ltd a company within Shanghai Pharmaceuticals group.

Licenced countries in Asia are; China, Japan, India, Indonesia, Philippines, Malaysia, Hong Kong, Macao, Thailand, South Korea, Taiwan and Singapore.


Visit website